|
Article Excerpt
SAN DIEGO, July 31 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing recombinant human enzymes, today announced that Connie Matsui has been named to its Board of Directors. Ms. Matsui is Executive Vice President, Corporate Strategy and Communications of Biogen Idec .
"We are thrilled to welcome Connie Matsui to our Board," said Jonathan Lim, MD, Halozyme's President and CEO. "Connie brings 30 years of general management, marketing, business building, change management, and other invaluable experience to Halozyme. She has spent the last 14 years helping grow IDEC Pharmaceuticals from a $30 million company when she first joined, into the...
|
|
More articles from PR Newswire
DreamFactory Announces Four Adaptive On-Demand Applications., July 31, 2006
MaXXan Achieves IBM System Storage Proven Designation., July 31, 2006
SAVE THE DATE: AIDS Healthcare Foundation Presents AfricAlive: Portrai..., July 31, 2006
SAVE THE DATE: AIDS Healthcare Foundation to Spearhead Global March an..., July 31, 2006
Gaiam, Inc. to Report Second Quarter 2006 Results., July 31, 2006
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
